Avalign Technologies Names Jeff McCaulley as CEO

Avalign Technologies appointed Jeff McCaulley as Chief Executive Officer. Former CEO Mr. Forrest Whittaker, who founded Avalign in 2005, will remain an active member of the Board of Directors.

Mr. McCaulley’s 30 years in the medical device industry includes experience as President of DJO Surgical and of Zimmer’s Global Reconstructive Division. Other leadership roles were held at Smiths Medical, Wolters Kluwer Health, Medtronic and GE Healthcare.

Avalign supplies implants, instruments, cutting tools, German Specialty Instruments and cases and trays for medical device OEMs. Mr. Whittaker has played a critical role in developing Avalign into the manufacturer and distributor that it is today.

“Participating in the growth and maturation of Avalign has been a fun, exciting, and often challenging experience. The management team and employee base of Avalign have created an exceptionally high-performance company that has been my privilege to lead,” Whittaker said. “I am very pleased and excited about Jeff’s appointment as Avalign’s CEO. He has established a superb track record of leading best-in-class companies in the medical device industry. We are most fortunate to have successfully recruited such a wonderful executive to take Avalign to its future levels of prosperity, growth, and success.”

Mr. Whittaker discussed Avalign with BONEZONE in 2010, explaining how it came together through various acquisitions.

Source: Avalign Technologies, Inc.

 

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE